Amivantamab
Lords · Question HL3236 · Tabled 5 Dec 2024 · Department of Health and Social Care · Official record
Answered 12 Dec 2024
Question
Asked by Lord Rogan
To ask His Majesty's Government what discussions they have had with the National Institute for Health and Care Excellence regarding the licensing of Amivantamab for the treatment of NHS cancer patients; and when they expect a licence to be granted.
Answer
Answered by Baroness Merron, 12 Dec 2024
Department officials have regular discussions with colleagues in the National Institute for Health and Care Excellence (NICE) about a range of issues, including access to new treatments for a range of diseases and conditions.Amivantamab was granted a cond...